| Breakdown | TTM | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 388.30M | 350.63M | 313.40M | 312.06M | 474.04M | 443.46M |
| Gross Profit | 277.99M | 246.92M | 215.40M | 192.13M | 341.64M | 310.79M |
| EBITDA | 19.49M | 9.38M | 573.00K | -77.35M | 29.73M | 47.43M |
| Net Income | -5.63M | -12.05M | -15.57M | -114.13M | -14.89M | 14.20M |
Balance Sheet | ||||||
| Total Assets | 514.90M | 497.82M | 472.08M | 443.08M | 664.61M | 628.82M |
| Cash, Cash Equivalents and Short-Term Investments | 106.59M | 112.72M | 74.48M | 52.09M | 163.02M | 83.28M |
| Total Debt | 37.22M | 35.53M | 33.36M | 16.97M | 124.59M | 69.99M |
| Total Liabilities | 287.38M | 280.72M | 257.35M | 233.30M | 365.52M | 358.45M |
| Stockholders Equity | 204.00M | 198.19M | 197.88M | 194.13M | 285.14M | 257.50M |
Cash Flow | ||||||
| Free Cash Flow | 26.38M | 33.59M | 25.49M | -48.67M | -15.16M | 51.98M |
| Operating Cash Flow | 39.05M | 46.78M | 34.56M | -36.99M | 2.63M | 71.31M |
| Investing Cash Flow | -15.05M | -5.69M | 9.36M | 20.13M | -17.85M | 16.42M |
| Financing Cash Flow | -24.15M | -7.95M | -2.45M | -102.93M | 58.74M | -205.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $2.27B | 38.01 | 28.84% | 1.66% | 3.30% | 31.18% | |
69 Neutral | $1.11B | 50.99 | 5.95% | ― | 10.40% | ― | |
63 Neutral | $610.60M | ― | -2.81% | ― | ― | ― | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | $2.32B | -78.26 | -10.29% | ― | 11.05% | 45.23% | |
49 Neutral | $415.79M | 42.08 | 22.00% | ― | 3.08% | -54.07% |
On March 3, 2026, Cognyte Software said its board approved a further $20 million increase to its share repurchase program, bringing total authorized buybacks to $40 million since the initiative launched in November 2024. The move underscores management’s emphasis on disciplined capital allocation and long-term shareholder value, backed by what the company describes as a strong balance sheet, steady cash generation and confidence in its growth outlook, with repurchases to be funded from existing cash and ongoing cash flows and executed in line with U.S. and Israeli regulations.
The most recent analyst rating on (CGNT) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Cognyte Software stock, see the CGNT Stock Forecast page.
On December 30, 2025, Cognyte Software Ltd. entered into amended and extended credit facility agreements with Bank Hapoalim and Bank Leumi, pushing back the scheduled expiration of its prior facilities from January 31, 2026 to January 31, 2028 and securing an aggregate credit line of $65 million. As of the filing date, Cognyte had no outstanding borrowings under either facility, and the updated arrangements, which include customary covenants and a specified non‑utilization fee structure, effectively lock in two additional years of committed bank financing, bolstering the company’s liquidity profile and financial flexibility without immediately increasing its leverage.
The most recent analyst rating on (CGNT) stock is a Hold with a $10.00 price target. To see the full list of analyst forecasts on Cognyte Software stock, see the CGNT Stock Forecast page.
On December 9, 2025, Cognyte Software Ltd. announced its financial results for the third quarter of fiscal year 2026, ending October 31, 2025. The company reported a 13.2% increase in revenue to $100.7 million compared to the previous year, and a significant improvement in operating income. Despite a GAAP net loss of $3.4 million due to increased tax expenses and foreign exchange impacts, the company achieved strong growth in adjusted EBITDA and improved cash flow. Cognyte’s strong performance and market momentum have led to an increased outlook for the fiscal year ending January 31, 2026, with expected revenue growth of approximately 14% and adjusted EBITDA growth of 60%.
The most recent analyst rating on (CGNT) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Cognyte Software stock, see the CGNT Stock Forecast page.